ADEFOVIR for Chronic hepatitis b: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 77 adverse event reports in the FDA FAERS database where ADEFOVIR was used for Chronic hepatitis b.
Most Reported Side Effects for ADEFOVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug resistance | 86 | 45.3% | 2 | 3 |
| Viral infection | 29 | 15.3% | 2 | 0 |
| Genotype drug resistance test | 27 | 14.2% | 0 | 0 |
| Pathogen resistance | 18 | 9.5% | 2 | 0 |
| Viral mutation identified | 17 | 9.0% | 2 | 0 |
| Osteomalacia | 14 | 7.4% | 0 | 8 |
| Treatment failure | 14 | 7.4% | 0 | 0 |
| Virologic failure | 13 | 6.8% | 0 | 0 |
| Hepatitis b dna increased | 12 | 6.3% | 2 | 0 |
| Hepatocellular carcinoma | 10 | 5.3% | 3 | 1 |
| Alanine aminotransferase increased | 9 | 4.7% | 0 | 0 |
| Condition aggravated | 9 | 4.7% | 4 | 7 |
| Drug ineffective | 9 | 4.7% | 1 | 1 |
| Hypophosphataemia | 9 | 4.7% | 0 | 5 |
| Pain | 8 | 4.2% | 0 | 5 |
Other Indications for ADEFOVIR
Other Drugs Used for Chronic hepatitis b
TENOFOVIR DISOPROXIL (1,156)
LAMIVUDINE (998)
ADEFOVIR DIPIVOXIL (776)
ENTECAVIR (705)
TENOFOVIR ALAFENAMIDE (679)
PEGINTERFERON ALFA-2A (234)
TENOFOVIR (187)
TELBIVUDINE (153)
EMTRICITABINE\TENOFOVIR DISOPROXIL (34)
PEGINTERFERON ALFA-2B (32)